{"id":344989,"date":"2026-08-19T15:48:12","date_gmt":"2026-08-19T15:48:12","guid":{"rendered":"https:\/\/www.europesays.com\/se\/344989\/"},"modified":"2026-08-19T15:48:12","modified_gmt":"2026-08-19T15:48:12","slug":"nytt-vaccin-kan-stoppa-aterfall-i-hudcancer-vetenskap","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/344989\/","title":{"rendered":"Nytt vaccin kan stoppa \u00e5terfall i hudcancer | Vetenskap"},"content":{"rendered":"

Forskare har tagit ett steg fram\u00e5t i kampen mot hudcancer med ett nytt vaccin som minskar risken f\u00f6r \u00e5terfall.<\/p>\n

\"En<\/p>\n

\u00d6ppna bildvisare<\/p>\n

Vaccinet kan m\u00f6jligen bli tillg\u00e4ngligt f\u00f6r patienter med h\u00f6griskmelanom redan n\u00e4sta \u00e5r. Bild: Getty ImagesLyssna (du h\u00f6r en artificiell r\u00f6st) 1:45<\/p>\n

Ett experimentellt vaccin kan minska risken f\u00f6r att den farligaste formen av hudcancer, melanom, kommer tillbaka efter operation.<\/p>\n

Det visar resultat fr\u00e5n en stor studie som l\u00e4kemedelsf\u00f6retagen Moderna och Merck presenterade p\u00e5 onsdagen.<\/p>\n

Studien omfattade drygt 1\u00a0100 patienter med melanom i ett sent stadium som hade opererats.<\/p>\n

De som fick det nya vaccinet tillsammans med cancerl\u00e4kemedlet Keytruda hade l\u00e4gre risk f\u00f6r att cancern skulle komma tillbaka eller sprida sig.<\/p>\n

S\u00e5 h\u00e4r fungerar vaccinet<\/p>\n

Vaccinet skiljer sig fr\u00e5n vanliga vacciner. I st\u00e4llet f\u00f6r att f\u00f6rebygga sjukdom behandlar det befintlig cancer genom att tr\u00e4na kroppens eget immunf\u00f6rsvar att bek\u00e4mpa cancertum\u00f6rer.<\/p>\n

Det \u00e4r f\u00f6rsta g\u00e5ngen ett cancervaccin baserat p\u00e5 mRNA-teknik visar s\u00e5 h\u00e4r goda resultat i en stor studie.<\/p>\n

Samma teknik anv\u00e4ndes i vaccinerna mot covid-19<\/a>.<\/p>\n

mRNA-vacciner fungerar annorlunda \u00e4n traditionella vacciner, som inneh\u00e5ller f\u00f6rsvagade eller neutraliserade virus. De inneh\u00e5ller genetisk kod som f\u00e5r kroppens egna celler att tillverka proteiner som immunf\u00f6rsvaret sedan reagerar p\u00e5.<\/p>\n

B\u00e5de den amerikanska och den europeiska l\u00e4kemedelsmyndigheten granskar behandlingen i snabbare takt \u00e4n vanligt.<\/p>\n

Enligt Modernas vd Stephen Hoge<\/strong> kan vaccinet m\u00f6jligen bli tillg\u00e4ngligt f\u00f6r patienter med h\u00f6griskmelanom redan n\u00e4sta \u00e5r.<\/p>\n

Melanom \u00e4r den d\u00f6dligaste formen av hudcancer. \u00d6ver 330\u00a0000 personer f\u00e5r diagnosen varje \u00e5r v\u00e4rlden \u00f6ver.<\/p>\n

K\u00e4llor: AFP, Reuters<\/p>\n","protected":false},"excerpt":{"rendered":"Forskare har tagit ett steg fram\u00e5t i kampen mot hudcancer med ett nytt vaccin som minskar risken f\u00f6r…\n","protected":false},"author":2,"featured_media":344990,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[65],"tags":[72,1761,2296,2928,1156,70,71,632,113,16752,2958,5953,34,674,10123,31,33,32,30,634,83,7065],"class_list":["post-344989","post","type-post","status-publish","format-standard","has-post-thumbnail","category-ekonomi","tag-business","tag-cancer","tag-cancersjukdomar","tag-coronavirus","tag-covid-19","tag-economy","tag-ekonomi","tag-forskning","tag-halsa","tag-hudcancer","tag-lakemedelsindustri","tag-melanom","tag-se","tag-sjukdomar","tag-studier","tag-svenska","tag-sverige","tag-sweden","tag-swedish","tag-vaccin","tag-vetenskap","tag-virus"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/117122964355796219","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/344989","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=344989"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/344989\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/344990"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=344989"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=344989"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=344989"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}